tiprankstipranks
Advertisement
Advertisement

Glanbia Cancels 35,921 Shares Under €50m Buyback Programme

Story Highlights
  • Glanbia repurchased and cancelled 35,921 shares on Euronext Dublin at an average price of €17.3511, leaving 243,417,887 ordinary shares in issue.
  • The buyback forms part of Glanbia’s up to €50 million share repurchase programme running to 30 September 2026, underscoring its confidence and focus on shareholder returns.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Glanbia Cancels 35,921 Shares Under €50m Buyback Programme

Claim 55% Off TipRanks

Glanbia ( (GLAPF) ) just unveiled an update.

Glanbia plc has repurchased 35,921 of its ordinary shares on Euronext Dublin via broker J&E Davy, paying a volume-weighted average price of €17.3511, with prices ranging between €17.32 and €17.38 per share. The company stated that all of these shares will be cancelled, reducing the number of ordinary shares in issue to 243,417,887.

The transaction forms part of Glanbia’s existing share buyback programme of up to €50 million, scheduled to run until 30 September 2026, which commenced on 25 February 2026. By continuing to execute this buyback, Glanbia is signaling confidence in its financial position and capital allocation strategy, potentially enhancing earnings per share and supporting shareholder returns over the programme period.

More about Glanbia

Glanbia plc is a global nutrition company focused on “better nutrition” products, operating primarily in the food and nutrition sector. It manufactures and sells nutritional ingredients and branded performance nutrition products, targeting health-conscious consumers and customers in international markets, and is listed on Euronext Dublin.

Find detailed analytics on GLAPF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1